
The Canara Robeco Emerging Equities Fund Direct-Growth is an equity mutual fund scheme offered by Canara Robeco Mutual Fund. As of February 22, 2025, the scheme boasts an Asset Under Management (AUM) of ₹23,338.91 Crores, with the latest Net Asset Value (NAV) declared at ₹257.740.
In terms of performance, the fund has delivered a return of 11.02% over the past year. Over a three-year period, the returns stand at an impressive 49.31%. Since its inception, the scheme has generated a remarkable cumulative return of 825.46%, showcasing its strong growth trajectory over the years.
Canara Robeco Emerging Equities Fund Return
Period | This fund | Category average |
---|---|---|
1 month | -3.57% | -3.94% |
3 months | -8.51% | -7.86% |
6 months | -10.69% | -11.29% |
1 year | 11.02% | 6.9% |
3 years | 14.25% | 16.83% |
5 years | 18.24% | 19.36% |
7 years | 14.91% | 15.01% |
10 years | 15.81% | 14.12% |
Canara Robeco Emerging Equities Fund Top 5 Holdings
Name | Sector | Instrument | Assets |
---|---|---|---|
ICICI Bank Ltd.
|
Financial | Equity | 7.07% |
The Indian Hotels Company Ltd.
|
Services | Equity | 5.13% |
Bharat Electronics Ltd.
|
Capital Goods | Equity | 4.04% |
Trent Ltd.
|
Services | Equity | 4.00% |
UNO Minda Ltd.
|
Automobile | Equity | 3.90% |
Sector Allocation in Canara Robeco Emerging Equities Fund
Sector | Allocation (%) | Amount (₹ Cr) |
---|---|---|
Financial | 20.35% | ₹4,749.47 |
Services | 16.32% | ₹3,808.91 |
Automobile | 14.11% | ₹3,293.13 |
Capital Goods | 13.10% | ₹3,057.40 |
Healthcare | 7.05% | ₹1,645.85 |
Others | 29.07% | ₹6,784.62 |
Disclaimer: Mutual fund investments are subject to market risks. Please read the scheme information document and other related documents carefully before investing. Past performance is not indicative of future results. The information provided in this article is for informational purposes only and should not be construed as investment advice or a recommendation. Readers are advised to seek independent financial advice before making any investment decisions. The author and the publication are not responsible for any investment losses incurred based on the information in this article.